Fantastic deal done by Cancer Research Technology - CTx's...

Fantastic deal done by Cancer Research Technology - CTx's commercialisation partner in the UK.

That said, the $730m are biodollars, not real money. There's US$15m up front, and it wouldn't be unreasonable to expect a big chunk of that to go in Fees to Cancer Research Technology. However, down the track, should the milestones be met and the product get approved, there may be up to US$500m in royalties split between the commercial partners.